Results 211 to 220 of about 6,127,278 (290)
Defensins, gasdermins and MLKL are distinct innate immune effectors with membrane disrupting activities that span antimicrobial defence and inflammatory cell death. This review compares the structure and function of these key molecules across four connected processes of (1) protein expression and activation, (2) lipid specific recognition and ...
Serenay B. Demir +3 more
wiley +1 more source
Parental KIR/HLA-C Profiles and Reproductive Failure: A Phenotype-Stratified Retrospective Analysis of Couples With Fertility Disorders. [PDF]
Černá K +6 more
europepmc +1 more source
This systematic review establishes disease‐specific dysregulations of human innate lymphoid cells (ILCs), demonstrating that an ILC1/ILC3 imbalance compromises mucosal barriers in inflammatory bowel disease, while activated ILC2s drive allergic airway inflammation.
Luan F. Lückmann +7 more
wiley +1 more source
Ascites reprograms innate lymphoid immune cells in ovarian cancer by promoting ILC2 enrichment and dysfunctional NK-cell states. [PDF]
Alashkar Alhamwe B +11 more
europepmc +1 more source
Natural Killer (NK) cells are potent effectors against virus‐infected and tumour cells. During Friend Virus (FV) infection, fatty acid metabolism supports NK‐cell effector functions. Here, we found that NK cells from FV‐infected mice preferentially take up linoleic acid (LA), which reduced proliferation, mitochondrial function, and increased reactive ...
Vaasudevan Sridhar +8 more
wiley +1 more source
Global patterns of KIR genotype diversity reflect human migration and regional differences. [PDF]
Barani S +4 more
europepmc +1 more source
Unlike generalized mTOR inhibitors, Torin‐1 uniquely drives compensatory upregulation of TIM‐3 on human NK cells, shielding them from immunosuppression while concurrently inhibiting glioblastoma (GBM) growth. Selecting or preconditioning ex vivo NK cell products for high TIM‐3 expression can offer a combination strategy for adoptive cell therapy in GBM.
Yuning Liu +11 more
wiley +1 more source
Developing immunotherapies through glycosylation reprogramming to combat solid cancers. [PDF]
Toyofuku T, Kumanogoh A.
europepmc +1 more source
Determinants of T Cell Exhaustion: How Far Back Can We Go?
Classical versus Emerging models of CD8+ T Cell Exhaustion. Comparison of the classical ‘Endpoint Model’ (Left), where exhaustion is viewed as a terminal state requiring reversal, versus the emerging ‘Trajectory Model’ (Right). Recent studies suggest exhaustion is a continuous developmental path initiated early in infection or tumuorigenesis ...
Testimony Olumade +2 more
wiley +1 more source
Immune proteomic associations with indices of cortical development in 5‐year‐old children
Typically developing 5‐year‐old children (n = 101–126) from the FinnBrain Birth Cohort Study, Finland, underwent both targeted serum immune proteomics and magnetic resonance brain imaging. Multiple inflammatory markers, from one cluster of co‐expressed immune proteins, were negatively associated with indices of cortical development, including thickness,
Aaron Barron +15 more
wiley +1 more source

